TrialLiver international : official journal of the International Association for the Study of the Liver2025

Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48.

Tarik Asselah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.